Subject characteristics, pulmonary function data (% predicted), exhaled NO (FENO) concentrations, and exhaled breath condensate (EBC) volumes
| Asthma (n=15) | |||
|---|---|---|---|
| Acute exacerbation (T1) | After 5 days prednisone (T2) | Controls (n=10) | |
| **Data are expressed as median and interquartile range (IQR). | |||
| *p=NS v T2; †p<0.001 v T1; ‡p=NS v T1; | |||
| Mean age (years) | 11.0 (range 6–16) | 10.1 (range 4–14) | |
| Atopy | 15 | None | |
| FEV1 (% pred)** | 59 (55–89) | 91 (75–105)† | 96 (92–98)†* |
| FENO (ppb)** | 34.7 (16.9–77.6) | 16.9 (11.0–39.1)† | |
| EBC volume (ml)** | 1.5 (1.2–1.7) | 1.4 (0.8–1.6)‡ | 1.5 (1.3–1.5)‡* |